NIH RESEARCH PROJECT-"TARGETED THERAPY FOR BURKITT LYMPHOMA

UNCLAS BRASILIA 001880 SIPDIS SIPDIS STATE PASS TO DHHS/NIH/FIC FOR KEVIN BIALY E.O. 12958: N/A TAGS: TBIO KSCA OSCI BR SUBJECT: NIH RESEARCH PROJECT-"TARGETED THERAPY FOR BURKITT LYMPHOMA IN RESOURCE POOR SETTINGS" REF: STATE 108008 ¶1. On August 30, 2006, Embassy delivered to Secretary Everton F. Lucero, Head of the Division of Science and Technology, Ministry of Foreign Affairs (DCTEC/MFA),for review and approval, the National Institutes of Health's (NIH) proposed award of a research project titled "Targeted Theraphy for Burkitt Lymphoma in Resource Poor Settings," (number CA121935-01). The site covered in this project is under the direction of Dr. Jose Barreto and Dr. Iguaracyra Araujo, from Federal University of Bahia, Salvador (Bahia),Brazil. ¶2. The Embassy sees no adverse foreign policy implications with respect to this research project. We emphasize the importance of complying with Brazilian laws on the export of data and biological material. ¶3. We are providing this assessment of foreign policy implications in advance of receiving approval from the Brazilian Government for the proposed research to go forward, in order to assist NIH in completing the domestic review process. Upon receipt of Brazilian approval, the Embassy will notify NIH by cable. CHICOLA